Is it alright to pay people to blog about a product?

Abbott recently put out an app for the iPhone regarding its infant formula Similac. The app “can easily track baby’s eating, sleeping … diaper changes … [and] predict the next feeding time”. Now the controversy of formula substituting for breast milk is an old one. My dad, who was with UNICEF, was one of the … Continue reading

Insurers dictate healthcare treatment

While the payment of doctors to act as spokespeople raises red flags amongst the public, who’s really influencing physician prescribing habits? Is it the pharmaceuticals? Certainly, the money trail laid out by ProPublica (see previous blog) would seem to indicate that. However, the Tufts Center for the Study of Drug Development (2008 Outlook report) found that … Continue reading

Why paid KOLs?

When the ProPublica “Dollars for Docs” database went out late last year, there was a lot of handwringing that went something like this — “How can we not pay our KOLs?” My reply (or question, if you will) — “Why do you need a paid KOL?” Paying KOLs raises questions of authenticity of the endorsement … Continue reading